---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-002817"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2022-03-03T23:59:59+00:00"
generated_at: "2026-06-27T02:07:39.724215+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# agilon health Q4 revenue up 44% to $463M; FY2021 net loss $407M; guides to positive Adj EBITDA in 2022

## Summary
- Q4 revenue $463M (+44% YoY); FY2021 revenue $1.83B (+50%).
- Net loss widened to $57M in Q4 (vs $24M); FY2021 net loss $407M (incl $292M stock comp).
- Adjusted EBITDA loss $27M in Q4; FY2021 loss $39M vs $6M gain in 2020.
- Total members live on platform up 82% to 238,000; Medicare Advantage members up 42% to 186,300.
- FY2022 guidance: revenue $2.505B-$2.590B; Adj EBITDA $0-$10M; adds 80,000 MA members from 7 new partners in 2023.

## SEC filing metadata
- accession: 0000950170-22-002817
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2022-03-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000095017022002817/0000950170-22-002817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000095017022002817/agl-20220303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-002817
- JSON: https://secwatch.observer/filing/0000950170-22-002817.json
- Plain text: https://secwatch.observer/filing/0000950170-22-002817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.